TY - JOUR
T1 - Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy
AU - Kikuchi, Daisuke
AU - Furuhata, Tsukasa
AU - Iizuka, Toshiro
AU - Yamada, Akihiro
AU - Yamashita, Satoshi
AU - Fujimoto, Ai
AU - Nakamura, Masanori
AU - Matsui, Akira
AU - Mitani, Toshifumi
AU - Ogawa, Osamu
AU - Hoteya, Shu
AU - Kaise, Mitsuru
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/6
Y1 - 2012/6
N2 - The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.
AB - The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.
UR - http://www.scopus.com/inward/record.url?scp=84864267896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864267896&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84864267896
VL - 54
SP - 1806
EP - 1811
JO - Gastroenterological Endoscopy
JF - Gastroenterological Endoscopy
SN - 0387-1207
IS - 6
ER -